{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:42:18Z","timestamp":1762004538364},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijantimicag.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T17:33:03Z","timestamp":1379093583000},"page":"497-499","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Minocycline, often forgotten but preferred to trimethoprim\u2013sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections"],"prefix":"10.1016","volume":"42","author":[{"given":"Burke A.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2013.08.006_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2005.01162.x","article-title":"Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy","volume":"11","author":"Cunha","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhin.2004.09.016","article-title":"Oral antibiotic treatment of MRSA infections","volume":"60","author":"Cunha","year":"2005","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0015","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.amjmed.2008.06.028","article-title":"Cephalexin remains preferred oral antibiotic therapy for uncomplicated cellulitis","volume":"121","author":"Cunha","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim\u2013sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2013.08.006_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/1120009X.1997.12113187","article-title":"Problems arising in antimicrobial therapy due to false susceptibility testing","volume":"9","author":"Cunha","year":"1997","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.mcna.2006.07.009","article-title":"Oral antibiotic therapy of serious systemic infections","volume":"90","author":"Cunha","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0035","series-title":"Antibiotic essentials","first-page":"1","year":"2013"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijantimicag.2010.01.017","article-title":"Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness","volume":"35","author":"Cunha","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/598510","article-title":"Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300","volume":"48","author":"Schwartz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0050","series-title":"Kucers\u2019 the use of antibiotics","first-page":"719","author":"Kucers","year":"1997"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0055","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.00206-07","article-title":"Prospective randomized trial of empiric therapy with trimethoprim\u2013sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus","volume":"51","author":"Cenizal","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/cid\/cir247","article-title":"Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim\u2013sulfamethoxazole","volume":"52","author":"De Angelis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1592\/phco.25.2.253.56956","article-title":"Trimethoprim\u2013sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus","volume":"25","author":"Grim","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0070","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Proctor","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1684\/ejd.2012.1864","article-title":"Management of mild CA-MRSA skin infections: more complicated than it looks at a glance","volume":"22","author":"P\u00e1rez","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/AAC.01244-06","article-title":"Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic","volume":"51","author":"Szumowski","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/joc.2009.21.2.115","article-title":"Trimethoprim\u2013sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative?","volume":"21","author":"Pappas","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.006_bib0095","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1128\/AAC.01011-12","article-title":"Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim\u2013sulfamethoxazole use and resistance?: a 10-year time series analysis","volume":"56","author":"Wood","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T05:08:52Z","timestamp":1646543332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924857913002963"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline, often forgotten but preferred to trimethoprim\u2013sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}